Back to search

Aristotle University Of Thessaloniki (AUTH)

Η επίδραση των από του στόματος χορηγούμενων αντιπηκτικών φαρμάκων στην οστική ενσωμάτωση ορθοπαιδικών εμφυτευμάτων: πειραματική μελέτη σε επίμυες

Abstract

dc:description

Thromboprophylaxis reduces the risk of surgery related deep venous thrombosis and pulmonary embolism. The classical anticoagulants (heparin and low weight molecular heparins) were associated with systemic osteoporosis, poor bone healing and materials’ osseointegration. There is a lack of data concerning the effect of the new orally administered anticoagulants on osseointegration. The aim of this study is to investigate the possible effect of rivaroxaban, a direct anti- Xa factor, on osseointegration. Twenty eight white, male, Wistar rats were divided into two groups: group A, study group (n=14) and group B, control group (n=14). In all animals under general anaesthesia two special custom-made screws were inserted, one on the proximal third of each tibia. For twenty eight days the animals of group A received intraperitoneal rivaroxaban injections 5mgr/kgr every day, which is the therapeutic dose for the humans. The solution was prepared after pulverization, dialysis with DMSO, stirring and centrifugation. The animals of group B received intraperitoneal equal amount of normal saline injections for the same period. At the end of the four weeks all animals were sacrificed and all the tibias were excised. Fourteen right tibias of group A and fourteen right tibias of group B underwent the pull-out test and fourteen left tibias of group A and fourteen left tibias of group B underwent the torque test in special modified experimental device named “PROCRUSTIS”. Also, before the animals’ sacrifice we received blood for biochemical indexes of bone metabolism (Alkaline Phospatase and bone portion of ALP., Osteocalcin, and CTX). The mean values of pull-out test were 92,1 ± 19,12 N for the control group (group B) and 95,46 ± 21,02 N for the study group (group A). The mean values for the torque test were 4,71 ± 0,34 Nmm for the control group (group B) and 5,52 ± 0,70 Nmm for the study group (group A). The statistical analysis using t-test showed that the statistical difference was not significant (p=0,665) for the pull-out test and slightly significant (p=0,001) for the torque test. Also, we did not find a significant difference of mean values of biochemical bone indexes between the two groups. These results indicate that at least Rivaroxaban hasn’t got any deleterious effect on osseointegration of implants on rats. Of course, we need larger and more sophisticated in vitro and in vivo studies in the future, in order to understand the multifactorial phenomenon of osseointegration as well as to confirm the effect of the new anticoagulants on this.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2017

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Kapetanou, Artemis
  • Καπετάνου, Άρτεμις

Subjects

dc:subject × 12

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/41005

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Kapetanou, Artemis; Καπετάνου, Άρτεμις. Η επίδραση των από του στόματος χορηγούμενων αντιπηκτικών φαρμάκων στην οστική ενσωμάτωση ορθοπαιδικών εμφυτευμάτων: πειραματική μελέτη σε επίμυες. Aristotle University Of Thessaloniki (AUTH), 2017. http://hdl.handle.net/10442/hedi/41005